Voriconazole
Find information on thousands of medical conditions and prescription drugs.

Voriconazole

Voriconazole (Vfend®, Pfizer) is a triazole antifungal medication used to treat serious fungal infections. It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These infections include invasive candidiasis and aspergillosis. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Administration

Oral (in tablets or suspension) or intravenous. Voriconzole interacts with many medications, including drugs given to suppress the immune system in transplant patients (e.g. cyclosporine, etc.).

Side effects

Common side effects include:

  • Blurred vision, increased eye sensitivity to light, or other visual changes
  • Nausea, vomiting, or diarrhea
  • Headache
  • Swelling or water retention.

Rare but life-threatening side effects include:

  • Severe liver damage
  • Allergic reactions to the medication

Read more at Wikipedia.org


[List your site here Free!]


Voriconazole versus itraconazole for fungal prophylaxis after lung transplantation
From CHEST, 10/1/05 by John H. Sherner

PURPOSE: Aspergillus and other fungal infections are common causes of morbidity and mortality in lung transplant recipients. Most patients receive prophylaxis against fungal infections, but the optimal regimen has not been defined. The purpose of this study was to assess the efficacy of voriconazole as fungal prophylaxis.

METHODS: We retrospectively reviewed data from 56 lung transplant recipients. Group A (n = 23) consisted of patients who underwent transplantation after the introduction of voriconazole prophylaxis. Group B (n=23) consisted of patients transplanted immediately prior to the introduction of voriconazole, in whom itraconazole was used as prophylaxis. Both groups received inhaled amphotericin B during their initial hospitalization adn continued oral antifungal prophylaxis until one year post-transplantation. The primary endpoint was positive BAL fungal cultures during the first year. We also assessed clinical events related to aspergillus and overall mortality.

RESULTS: The incidence of patients with positive bronchial cultures for aspergillus at 1 year was 5/28 (18%) in the group A and 10/28 (36%) in group B (p = 0.134, ns). At the time of recovery of aspergillus, 4/5 (80%) patients in group A were actually receiving voriconazole, versus 90% (9/10) in group B receiving itraconazole. The incidence of patients with positive bronchial cultures for candida was 0 in group A versus 50% (14/28) in group B (p = < 0.0001). At one year, there was one clinical aspergillus event in each group, non-fatal in group A and fatal in group B. There was an additional fatal aspergillus event in group B at month 25, as well as an episode of scedosporium sepsis at month 13.

CONCLUSION: In our lung transplant population, the use of voriconazole results in decreased airway colonization with aspergillus and candida.

CLINICAL IMPLICATIONS: These findings suggest that voriconazole is effective antifungal prophylaxis for lung transplant recipients. The overall low rate of clinically significant fungal events do not allow any further conclusions to be drawn.

DISCLOSURE: John Sherner, None.

John H. Sherner MD * Scott Barnett PhD Shahzad Ahmad MD Nelson Burton MD Mary Schmidt MD Steven Nathan MD Walter Reed Army Medical Center, Washington, DC

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Voriconazole
Home Contact Resources Exchange Links ebay